SCHEMBL4351664

SCHEMBL4351664

C=CCOc1cccc(NC(=O)OCC)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.59
SMN1; SMN2 Q16637 3/20 0.58
MAPT P10636 4/20 0.57
NPSR1 Q6W5P4 2/20 0.57
MTNR1B P49286 2/20 0.56
MAPK1 P28482 3/20 0.56
HSD17B10 Q99714 3/20 0.56
LMNA P02545 2/20 0.56
TSHR P16473 1/20 0.54
ALDH1A1 P00352 1/20 0.53
NPC1 O15118 4/20 0.52
HTT P42858 2/20 0.52
RAB9A P51151 4/20 0.50
HPGD P15428 2/20 0.50
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
F2R P25116 1/20 0.49
KDM4E B2RXH2 1/20 0.48
POLB P06746 1/20 0.48
CYP1A2 P05177 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23121252 0.85 GAA (0.62) GAASMN1; SMN2MAPTMAPK1ALDH1A1
SCHEMBL11718411 0.84 GAA (0.54) GAASMN1; SMN2MAPTNPSR1HSD17B10
SCHEMBL11717437 0.84 GAA (0.54) GAASMN1; SMN2MAPTNPSR1HSD17B10
SCHEMBL4980566 0.83 GAA (0.64) GAASMN1; SMN2MAPTMTNR1BMAPK1
SCHEMBL29816965 0.83 GAA (0.58) GAASMN1; SMN2MAPTALDH1A1NPC1
SCHEMBL23142737 0.83 GAA (0.58) GAASMN1; SMN2MAPTALDH1A1NPC1
SCHEMBL14045181 0.82 GAA (0.59) GAASMN1; SMN2MAPTMTNR1BMAPK1
SCHEMBL9340695 0.81 SMN1; SMN2 (0.67) GAASMN1; SMN2MAPTNPSR1MTNR1B
SCHEMBL6647977 0.80 MTNR1B (0.82) GAASMN1; SMN2MAPTNPSR1MTNR1B
SCHEMBL7565149 0.80 MAPK1 (0.81) SMN1; SMN2MAPTMTNR1BMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576034-B2 Crosslinked three-dimensional polymer network, method for preparing same, support material comprising same and uses thereof EKA CHEMICALS AB (SE) 2009-08-18 US claimed
US-20040260081-A1 Crosslinked three-dimensional polymer network, method for preparing same, support material comprising same and uses thereof EKA CHEMICALS AB (SE) 2004-12-23 US claimed
EP-1427525-A2 CROSSLINKED THREE-DIMENSIONAL POLYMER NETWORK, METHOD FOR PREPARING SAME, SUPPORT MATERIAL COMPRISING SAME AND USES THEREOF Chirosep (FR) 2004-06-16 EP claimed
WO-2003026793-A2 CROSSLINKED THREE-DIMENSIONAL POLYMER NETWORK, METHOD FOR PREPARING SAME, SUPPORT MATERIAL COMPRISING SAME AND USES THEREOF EKA CHEMICALS AB (SE) 2003-04-03 WO claimed
US-7576034-B2 Crosslinked three-dimensional polymer network, method for preparing same, support material comprising same and uses thereof EKA CHEMICALS AB (SE) 2009-08-18 US disclosed
EP-1606320-B1 CROSSLINKED THREE-DIMENSIONAL POLYMER NETWORK, METHOD FOR PREPARING SAME, SUPPORT MATERIAL COMPRISING SAME AND USES THEREOF CHIROSEP (FR) 2007-06-13 EP disclosed
EP-1606320-A1 CROSSLINKED THREE-DIMENSIONAL POLYMER NETWORK, METHOD FOR PREPARING SAME, SUPPORT MATERIAL COMPRISING SAME AND USES THEREOF CHIROSEP (FR) 2005-12-21 EP disclosed
US-20040265267-A1 Crosslinked three-dimensional polymer network, method for preparing same, support material comprising same and uses thereof CHIROSEP (FR) 2004-12-30 US disclosed
US-20040260081-A1 Crosslinked three-dimensional polymer network, method for preparing same, support material comprising same and uses thereof EKA CHEMICALS AB (SE) 2004-12-23 US disclosed
WO-2004085485-A1 CROSSLINKED THREE-DIMENSIONAL POLYMER NETWORK, METHOD FOR PREPARING SAME, SUPPORT MATERIAL COMPRISING SAME AND USES THEREOF CHIROSEP (FR) 2004-10-07 WO disclosed
EP-1427525-A2 CROSSLINKED THREE-DIMENSIONAL POLYMER NETWORK, METHOD FOR PREPARING SAME, SUPPORT MATERIAL COMPRISING SAME AND USES THEREOF Chirosep (FR) 2004-06-16 EP disclosed
WO-2003026793-A2 CROSSLINKED THREE-DIMENSIONAL POLYMER NETWORK, METHOD FOR PREPARING SAME, SUPPORT MATERIAL COMPRISING SAME AND USES THEREOF EKA CHEMICALS AB (SE) 2003-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040265267-A1 Crosslinked three-dimensional polymer network, method for preparing same, support material comprising same and uses thereof UROD, ALG1, NOTUM GAA 4634/4885SMN1; SMN2 3848/4885MAPT 1394/4885
US-20040260081-A1 Crosslinked three-dimensional polymer network, method for preparing same, support material comprising same and uses thereof MTCL3, OR10J3, MCM4 GAA 4638/4885SMN1; SMN2 4169/4885MAPT 660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.